India to continue to allow the sale of Ranitidine, a drug under scrutiny for potential cancer risks due to NDMA impurities.

While a stuffy nose is a common side effect of oral ED medications, switching from Cialis to shorter-lasting options like ...

The U.S. Food and Drug Administration (FDA) has approved a generic daily injectable for the GLP-1 medication for patients who ...

UNITED STATES - A new generic treatment option for people with type 2 diabetes has been approved by the FDA. The generic ...

Duquesne Family Office's chief is cashing in his chips on two leading artificial intelligence (AI) stocks in favor of a ...

“Generics typically offer a more affordable option compared to brand-name drugs, which could increase accessibility for patients ... In a Monday news release, the FDA said it “prioritizes the ...

“This bipartisan legislation will promote generic drug competition and improve patient access to lower-cost medications,” said Senator Collins. “By reaffirming the so-called ‘skinny label’ pathway, ...

The drugs were first approved to treat type 2 diabetes – and that's what the FDA said daily injections of liraglutide could ...

FDA approves Hikma Pharmaceuticals' generic version of Victoza, a once-daily GLP-1 injection for Type 2 diabetes. Other drugmakers also entering the market.

The FDA has approved the first generic form of liraglutide (Victoza), a once-daily injectable for improving glycemic control ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...